Separate current trading from historical accounts
The latest selected financial period is 2023-03-31. A recent market quote or a new scoring timestamp does not update those accounts.
| Symbol | Name | Exchange | Last | Change | Volume | Watch |
|---|
CIN RESEARCH · DATED EVIDENCE
Historical financial evidenceThe available financial series reaches March 31, 2023; current financial conclusions are withheld.
The check time records a research refresh. Each financial figure and price keeps its own reporting date.
The latest selected financial period is 2023-03-31. A recent market quote or a new scoring timestamp does not update those accounts.
| Measure | Reported value & unit | Period & interval | Evidence basis |
|---|---|---|---|
| RevenueHistorical observation | CAD 42.85mUnit: CAD | Annual period | Dated financial series |
| Cost of revenueHistorical observation | CAD 36.85mUnit: CAD | Annual period | Dated financial series |
| Gross profitHistorical observation | CAD 6mUnit: CAD | Annual period | Dated financial series |
| Operating incomeHistorical observation | CAD -17.54mUnit: CAD | Annual period | Dated financial series |
| EBITDAHistorical observation | CAD -10.97mUnit: CAD | Annual period | Dated financial series |
| Cash balanceHistorical observation | CAD 465,000Unit: CAD | Balance at period end | Dated financial series |
| Total assetsHistorical observation | CAD 59.93mUnit: CAD | Balance at period end | Dated financial series |
| Total liabilitiesHistorical observation | CAD 68.84mUnit: CAD | Balance at period end | Dated financial series |
| Shareholders’ equityHistorical observation | CAD -8.91mUnit: CAD | Balance at period end | Dated financial series |
| Operating cash flowHistorical observation | CAD -3.48mUnit: CAD | Annual period | Dated financial series |
| Free cash flowHistorical observation | CAD -5.13mUnit: CAD | Annual period | Dated financial series |
A balance at period end is not income over a period. “Quarterly series” follows the available classification; the source disclosure establishes the actual reporting interval.
Independent evidence summary. No broker consensus, price target or investment rating is manufactured. Research standards →
CONTINUE YOUR RESEARCH